Informatie:
Fout:
ID
34583
Beschrijving
Diabetes & Vardenafil; ODM derived from: https://clinicaltrials.gov/show/NCT02219646
Link
https://clinicaltrials.gov/show/NCT02219646
Trefwoorden
Versies (1)
- 19/01/19 19/01/19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
19 gennaio 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Type 2 Diabetes Mellitus (T2DM) NCT02219646
Eligibility Type 2 Diabetes Mellitus (T2DM) NCT02219646
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes Mellitus (T2DM) NCT02219646
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
male gender
boolean
ID.2
Item
signed written consent form
boolean
ID.3
Item
type 2 diabetes mellitus diagnosed within 5 years before enrolment in the study
boolean
ID.4
Item
body mass index (bmi) < 35
boolean
ID.5
Item
ed (severe, moderate or light according to the international index of erectile function - erectile function domain score < 26 (rosen et al. 1997))
boolean
ID.6
Item
age range: 40-65 years.
boolean
ID.7
Item
systemic diseases except type 2 diabetes mellitus
boolean
ID.8
Item
absence of ed
boolean
ID.9
Item
psychiatric disorders
boolean
ID.10
Item
all contraindications to treatment with pde5 inhibitors, such as retinitis pigmentosa, non-arteritic anterior ischaemic optic neuropathy, history of coronary artery disease, recent myocardial infarction, unstable angina, systemic arterial hypotension, nitric-oxide donors therapy, severe hepatic and renal failure.
boolean